Poseida Therapeutics, Inc. Interest Expense
Poseida Therapeutics, Inc. reported Interest Expense of $2.29 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2024-11-07
- Poseida Therapeutics, Inc. interest expense for the quarter ending 2024-09-30 was $2.29M, a 2.64% increase year-over-year.
- Poseida Therapeutics, Inc. interest expense for the quarter ending 2024-06-30 was $2.26M, a 5.51% increase year-over-year.
- Poseida Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $2.25M, a 11.09% increase year-over-year.
- Poseida Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $2.27M, a 14.78% increase year-over-year.
- Poseida Therapeutics, Inc. interest expense for fiscal 2023 was $8.67M, a 36.12% increase from fiscal 2022.
- Poseida Therapeutics, Inc. interest expense for fiscal 2022 was $6.37M, a 89.70% increase from fiscal 2021.
- Poseida Therapeutics, Inc. interest expense for fiscal 2021 was $3.36M, a 4.22% decline from fiscal 2020.
- Poseida Therapeutics, Inc. interest expense for fiscal 2020 was $3.51M, a 1.32% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $2.29M 10-Q · filed 2024-11-07 | $4.55M derived: sum of 2 quarters · filed 2024-11-07 | $6.81M 10-Q · filed 2024-11-07 | $9.07M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | $2.26M 10-Q · filed 2024-08-05 | $4.51M 10-Q · filed 2024-08-05 | $6.78M derived: sum of 3 quarters · filed 2024-08-05 | $9.02M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-03-31 | $2.25M 10-Q · filed 2024-05-14 | $4.52M derived: sum of 2 quarters · filed 2024-05-14 | $6.76M derived: sum of 3 quarters · filed 2024-11-07 | $8.90M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $4.50M derived: sum of 2 quarters · filed 2024-11-07 | $6.64M derived: sum of 3 quarters · filed 2024-11-07 | $8.67M 10-K · filed 2024-03-07 | |
| 2023-09-30 | $2.24M 10-Q · filed 2024-11-07 | $4.38M derived: sum of 2 quarters · filed 2024-11-07 | $6.40M 10-Q · filed 2024-11-07 | $8.38M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $2.14M 10-Q · filed 2024-08-05 | $4.17M 10-Q · filed 2024-08-05 | $6.14M derived: sum of 3 quarters · filed 2024-08-05 | $7.92M derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-14 | $4.00M derived: sum of 2 quarters · filed 2024-05-14 | $5.78M derived: sum of 3 quarters · filed 2024-05-14 | $4.24M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $3.75M derived: sum of 2 quarters · filed 2024-03-07 | $2.21M derived: sum of 3 quarters · filed 2024-03-07 | $6.37M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.77M 10-Q · filed 2023-11-09 | $232.00K derived: sum of 2 quarters · filed 2023-11-09 | $4.39M 10-Q · filed 2023-11-09 | $2.15M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$1.54M 10-Q · filed 2023-08-08 | $1.54M 10-Q · filed 2022-08-11 | $2.62M 10-Q · filed 2023-08-08 | $374.00K derived: sum of 3 quarters · filed 2023-08-08 | $1.21M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.08M 10-Q · filed 2023-05-09 | $1.92M derived: sum of 2 quarters · filed 2023-05-09 | $2.75M derived: sum of 3 quarters · filed 2023-05-09 | $3.60M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.68M derived: sum of 2 quarters · filed 2023-03-09 | $2.52M derived: sum of 3 quarters · filed 2023-03-09 | $3.36M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $837.00K 10-Q · filed 2022-11-10 | $1.68M derived: sum of 2 quarters · filed 2022-11-10 | $2.52M 10-Q · filed 2022-11-10 | $3.37M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $843.00K 10-Q · filed 2022-08-11 | $1.68M 10-Q · filed 2022-08-11 | $2.53M derived: sum of 3 quarters · filed 2022-08-11 | $3.38M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $838.00K 10-Q · filed 2022-05-12 | $1.69M derived: sum of 2 quarters · filed 2022-05-12 | $2.54M derived: sum of 3 quarters · filed 2022-05-12 | $3.43M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.70M derived: sum of 2 quarters · filed 2022-03-10 | $2.59M derived: sum of 3 quarters · filed 2022-03-10 | $3.51M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $848.00K 10-Q · filed 2021-11-09 | $1.74M derived: sum of 2 quarters · filed 2021-11-09 | $2.65M 10-Q · filed 2021-11-09 | $3.57M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $892.00K 10-Q · filed 2021-08-12 | $1.81M 10-Q · filed 2021-08-12 | $2.73M derived: sum of 3 quarters · filed 2021-08-12 | $3.66M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $914.00K 10-Q · filed 2021-05-11 | $1.83M derived: sum of 2 quarters · filed 2021-05-11 | $2.77M derived: sum of 3 quarters · filed 2021-05-11 | $3.67M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $920.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.85M derived: sum of 2 quarters · filed 2021-03-11 | $2.76M derived: sum of 3 quarters · filed 2021-03-11 | $3.55M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $935.00K 10-Q · filed 2020-11-12 | $1.84M derived: sum of 2 quarters · filed 2020-11-12 | $2.63M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $903.00K 10-Q · filed 2020-08-20 | $1.70M 10-Q · filed 2020-08-20 |